Literature DB >> 11928868

Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival.

Ozgul Sagol1, Burçin Tuna, Ahmet Coker, Sedat Karademir, Funda Obuz, Hüseyin Astarcioglu, Ali Küpelioglu, Ibrahim Astarcioglu, Omer Topalak.   

Abstract

We investigated pS2 and HSP-70 protein expression in 36 pancreatic adenocarcinomas for their effect on disease extent and patient outcome. The cases were reviewed, histologically diagnosed, typed, graded, and staged. Lymphatic vessel, blood vessel and perineural invasion as well as lymph node, resection margin and adjacent organ involvements were re-evaluated. The standard streptavidin biotin immunperoxidase method was used for immunostaining with pS2 and HSP-70 antibodies. Cytoplasmic staining with both antibodies was scored semiquantitatively. The scores were compared with histopathological prognostic parameters using statistical methods. Standard prognostic parameters and staining scores were tested by survival analysis in terms of their effect on survival. All the tumors showed a positive cytoplasmic reaction with HSP-70 antibody. Seventy-seven percent of the tumors showed positive cytoplasmic staining with pS2 antibody (22.2% +, 13.9% ++ and 41.7% +++). There was a statistically significant difference between HSP-70 staining scores with N status and final stages of the tumors (Chi-square, p = 0.03 and p = 0.026, respectively), while neither direct nor inverse correlation was detected for both parameters. PS2 staining scores showed no statistically significant relationship with tumor grade T, M status, perineural invasion, lymph and blood vessel invasion. In tumors with extensive staining with pS2, tumor stage tended to be low (Chi square, p = 0.024, Kendall Tau-b, r: -0.336, p = 0.036). There was a statistically significant difference and inverse correlation between tumors with extensive pS2 staining and tumors with less intense staining in terms of lymph node metastasis (Chi-square, p = 0.041, Kendall Tau: p = 0.024, r = -0,373). In the R0 resection group, in univariate analysis, we found that with higher scores of HSP-70 staining, the prognosis of the patient tended to improve. (Cox regression, p = 0.013). In multivariate analysis, HSP-70 expression was found to be an independent prognostic factor. We found no relationship between pS2 staining and patient survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11928868     DOI: 10.1078/0344-0338-00190

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

1.  Construction and selection of subtracted cDNA library of mouse hepatocarcinoma cell lines with different lymphatic metastasis potential.

Authors:  Li Hou; Jan-Wu Tang; Xiao-Nan Cui; Bo Wang; Bo Song; Lei Sun
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Authors:  Thiruvengadam Arumugam; Will Brandt; Vijaya Ramachandran; Tood T Moore; Huamin Wang; Felicity E May; Bruce R Westley; Rosa F Hwang; Craig D Logsdon
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

3.  Trefoil factor 1 acts to suppress senescence induced by oncogene activation during the cellular transformation process.

Authors:  Daniel R Radiloff; Timothy P Wakeman; Junjie Feng; Stephen Schilling; Edward Seto; Xiao-Fan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-30       Impact factor: 11.205

4.  Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma.

Authors:  Peter Kornprat; Peter Rehak; Martina Lemmerer; Margit Gogg-Kamerer; Cord Langner
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

5.  Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.

Authors:  R Jesnowski; Dmitri Zubakov; Ralf Faissner; Jörg Ringel; Jörg D Hoheisel; Ralf Lösel; Martina Schnölzer; Matthias Löhr
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

Review 6.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

7.  Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.

Authors:  Tomasz P Radon; Nathalie J Massat; Richard Jones; Wasfi Alrawashdeh; Laurent Dumartin; Darren Ennis; Stephen W Duffy; Hemant M Kocher; Stephen P Pereira; Luisa Guarner posthumous; Cristiane Murta-Nascimento; Francisco X Real; Núria Malats; John Neoptolemos; Eithne Costello; William Greenhalf; Nick R Lemoine; Tatjana Crnogorac-Jurcevic
Journal:  Clin Cancer Res       Date:  2015-08-01       Impact factor: 12.531

8.  Investigation into the potential for hypoxic interior of neoplasms to enhance HSPA expression in glioma.

Authors:  Glenda M Beaman; David A Phoenix; Sarah R Dennison; Lee K Chatfield
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

9.  Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma.

Authors:  Glenda Maria Beaman; Sarah R Dennison; Lee K Chatfield; David A Phoenix
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

10.  The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase.

Authors:  Francesco Cappello; Sabrina David; Francesca Rappa; Fabio Bucchieri; Lorenzo Marasà; Tommaso E Bartolotta; Felicia Farina; Giovanni Zummo
Journal:  BMC Cancer       Date:  2005-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.